$COMP

Reffkin Robert L. sold $5K of COMP (indirect holdings)

Reffkin Robert L. (Chairman and CEO) sold 600 indirectly-held shares of Compass, Inc. (COMP) at $8.28 on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Reffkin Robert L.
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$COMP
Neutral
high confidence
Mentioned
$COMP
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$COMPNeutralLow
01

Why it matters

The disclosure updates insider activity records but does not introduce new company-specific fundamentals (no earnings, guidance, deal, or litigation).

02

Market read

Traders may note the sale as routine insider activity; it is unlikely to drive a fundamental repricing.

03

What to watch

Insider sales can reflect diversification or liquidity needs rather than bearish expectations; without additional context (e.g., large trend of sales), signal is weak.

Relevance 3/10Novelty 2/10Timing: Filed June 5; transaction dated June 3 under a 10b5-1 plan

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by Compass CEO/Chairman under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$COMPNeutralHigh confidence
Context

Compass, Inc. disclosed an officer/director open-market sale of 600 shares under a pre-arranged 10b5-1 plan.

Expected impact

Likely negligible near-term price impact; any effect would be limited to short-term sentiment/flow.

Evidence & confidence

The filing is a routine Form 4 insider transaction, explicitly tied to a Rule 10b5-1 plan, with a modest $5k value relative to typical market capitalization.

Market effects

No clear sector read-through from a single small 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even pre-arranged sales can coincide with internal risk management; however, the disclosed size and 10b5-1 structure reduce interpretability.

Key entities

  • Compass, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Reffkin Robert L.

    Chairman and CEO who sold 600 shares on June 3, 2026.

Related articles

$COMPMed

COMP Stock Climbs As Earnings Beat Ignites Bullish Targets

Compass Inc. (NYSE: COMP) shares rose about 5.44% after the company reported Q2 results. According to the article, Q2 revenue was $4.31B versus $4.11B consensus, with EPS $0.11. Q3 guidance was $3.85B to $4.05B revenue and adjusted EBITDA $275M to $305M. UBS raised its COMP price target to $17 from $12.

$COMPMedAI 8/10

COMPASS Pathways Releases Q2 2026 Financial Results

COMPASS Pathways plc reported Q2 2026 results with a basic and diluted loss of $1.88 per share, versus a Wall Street expectation of a $0.41 loss. The company posted a net loss of $253.8M, widening from a year-ago $0.41 per-share loss. Analysts show 14 buys and 2 holds, with no sells.

$ZMed

BREAKING: Realtracs and Zillow Strike Deal to Avoid Listing Shut-Off

Realtracs, a Tennessee MLS, and Zillow reached a new licensing agreement after Realtracs threatened to cut off Zillow’s listing feed. Realtracs says the deal ensures uninterrupted distribution, defines approved uses including AI, preserves access to Zillow tools, and requires Zillow to notify the MLS if it bans listings. The dispute is linked to federal court cases involving MRED, Compass and Zillow.

$COMPHighAI 9/10

Why is Compass stock surging today?

Compass (COMP) shares rose about 9.5% pre-open after the company reported Q2 2026 results that beat expectations. EPS was $0.11 vs $0.09 forecast, revenue $4.31B vs ~$4.10B, and adjusted EBITDA hit a record $363M. Compass said Anywhere Real Estate synergies reached $300M in seven months, raised the target to $330M, and lifted Q3 revenue guidance to $3.85B-$4.05B. UBS and Barclays raised price targets.